<VariationArchive VariationID="667375" VariationName="NM_024996.7(GFM1):c.54del (p.Ala19fs)" VariationType="Deletion" Accession="VCV000667375" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-17" DateCreated="2019-08-26" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="654317" VariationID="667375">
      <GeneList>
        <Gene Symbol="GFM1" FullName="G elongation factor mitochondrial 1" GeneID="85476" HGNC_ID="HGNC:13780" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3q25.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="158644527" stop="158695581" display_start="158644527" display_stop="158695581" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="158362316" stop="158410360" display_start="158362316" display_stop="158410360" Strand="+" />
          </Location>
          <OMIM>606639</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_024996.7(GFM1):c.54del (p.Ala19fs)</Name>
      <CanonicalSPDI>NC_000003.12:158644683:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3q25.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="158644684" stop="158644684" display_start="158644684" display_stop="158644684" variantLength="1" positionVCF="158644683" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="158362473" stop="158362473" display_start="158362473" display_stop="158362473" variantLength="1" positionVCF="158362472" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>A19fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.158362477del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.158362477del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.158644688del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.158644688del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008441.1" sequenceAccession="NG_008441" sequenceVersion="1" change="g.5161del">
            <Expression>NG_008441.1:g.5161del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001308164.2" sequenceAccession="NM_001308164" sequenceVersion="2" change="c.54del">
            <Expression>NM_001308164.2:c.54del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001295093.1" sequenceAccession="NP_001295093" sequenceVersion="1" change="p.Ala19fs">
            <Expression>NP_001295093.1:p.Ala19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001308166.2" sequenceAccession="NM_001308166" sequenceVersion="2" change="c.54del">
            <Expression>NM_001308166.2:c.54del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001295095.1" sequenceAccession="NP_001295095" sequenceVersion="1" change="p.Ala19fs">
            <Expression>NP_001295095.1:p.Ala19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374355.1" sequenceAccession="NM_001374355" sequenceVersion="1" change="c.54del">
            <Expression>NM_001374355.1:c.54del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361284.1" sequenceAccession="NP_001361284" sequenceVersion="1" change="p.Ala19fs">
            <Expression>NP_001361284.1:p.Ala19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374356.1" sequenceAccession="NM_001374356" sequenceVersion="1" change="c.54del">
            <Expression>NM_001374356.1:c.54del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361285.1" sequenceAccession="NP_001361285" sequenceVersion="1" change="p.Ala19fs">
            <Expression>NP_001361285.1:p.Ala19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374357.1" sequenceAccession="NM_001374357" sequenceVersion="1" change="c.-338del">
            <Expression>NM_001374357.1:c.-338del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374358.1" sequenceAccession="NM_001374358" sequenceVersion="1" change="c.54del">
            <Expression>NM_001374358.1:c.54del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361287.1" sequenceAccession="NP_001361287" sequenceVersion="1" change="p.Ala19fs">
            <Expression>NP_001361287.1:p.Ala19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374359.1" sequenceAccession="NM_001374359" sequenceVersion="1" change="c.-176del">
            <Expression>NM_001374359.1:c.-176del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374360.1" sequenceAccession="NM_001374360" sequenceVersion="1" change="c.-176del">
            <Expression>NM_001374360.1:c.-176del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374361.1" sequenceAccession="NM_001374361" sequenceVersion="1" change="c.-176del">
            <Expression>NM_001374361.1:c.-176del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024996.7" sequenceAccession="NM_024996" sequenceVersion="7" change="c.54del" MANESelect="true">
            <Expression>NM_024996.7:c.54del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079272.4" sequenceAccession="NP_079272" sequenceVersion="4" change="p.Ala19fs">
            <Expression>NP_079272.4:p.Ala19fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164499.1" sequenceAccession="NR_164499" sequenceVersion="1" change="n.162del">
            <Expression>NR_164499.1:n.162del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164500.1" sequenceAccession="NR_164500" sequenceVersion="1" change="n.162del">
            <Expression>NR_164500.1:n.162del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164501.1" sequenceAccession="NR_164501" sequenceVersion="1" change="n.162del">
            <Expression>NR_164501.1:n.162del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_164502.1" sequenceAccession="NR_164502" sequenceVersion="1" change="n.162del">
            <Expression>NR_164502.1:n.162del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="765266988" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024996.7(GFM1):c.54del (p.Ala19fs) AND Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1" Accession="RCV000826110" Version="5">
        <ClassifiedConditionList TraitSetID="1142">
          <ClassifiedCondition DB="MedGen" ID="C1836797">Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-23" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_024996.7(GFM1):c.54del (p.Ala19fs) AND not provided" Accession="RCV002538243" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-03-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-23" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2019-08-26" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16632485</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17160893</ID>
        </Citation>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1142" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="990" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Combined oxidative phosphorylation deficiency 1</ElementValue>
                <XRef ID="Combined+oxidative+phosphorylation+deficiency+1/8013" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1</ElementValue>
                <XRef ID="MONDO:0012191" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE</ElementValue>
                <XRef Type="MIM" ID="609060" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">COXPD1</ElementValue>
                <XRef Type="MIM" ID="609060" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="16949" />
                <XRef ID="16949" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="137681" DB="Orphanet" />
              <XRef ID="C1836797" DB="MedGen" />
              <XRef ID="MONDO:0012191" DB="MONDO" />
              <XRef Type="MIM" ID="609060" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1895412" SubmissionDate="2019-03-21" DateLastUpdated="2019-08-26" DateCreated="2019-08-26">
        <ClinVarSubmissionID localKey="92585571|Orphanet:ORPHA137681" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000967618" DateUpdated="2019-08-26" DateCreated="2019-08-26" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-12-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>The p.Ala19ProfsX3 variant in GFM1 has not been previously reported in individua ls with combined oxidative phosphorylation deficiency. It has been identified in 1/80660 of European and 1/24940 South Asian chromosomes by gnomAD (http://gnoma d.broadinstitute.org). This variant is predicted to cause a frameshift, which al ters the protein?s amino acid sequence beginning at position 19 and leads to a p remature termination codon 3 amino acids downstream. This alteration is then pre dicted to lead to a truncated or absent protein. Loss of function of the GFM1 ge ne is associated with autosomal recessive combined oxidative phosphorylation def iciency. In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as like ly pathogenic for autosomal recessive combined oxidative phosphorylation deficie ncy. ACMG/AMP Criteria applied: PVS1_Strong, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GFM1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_024996.5:EXON 1</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_024996.5:c.54delC</Name>
            <Name>p.Ala19ProfsX3</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.158362477delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA137681" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348959</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="6012876" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="16160900|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003326122" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-03-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16632485</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17160893</ID>
          </Citation>
          <Comment>The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 667375). This variant has not been reported in the literature in individuals affected with GFM1-related conditions. This sequence change creates a premature translational stop signal (p.Ala19Profs*3) in the GFM1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GFM1 are known to be pathogenic (PMID: 16632485, 17160893).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GFM1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.158362473del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9819048" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_024996.7:c.54del|OMIM:609060" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005058974" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_024996.7:c.54del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609060" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9819048" TraitType="Disease" MappingType="XRef" MappingValue="609060" MappingRef="OMIM">
        <MedGen CUI="C1836797" Name="Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="6012876" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1895412" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA137681" MappingRef="Orphanet">
        <MedGen CUI="C1836797" Name="Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>